LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 6.94 | 771.67 | 1085 | 1045 | 1.0382 | 1.1787 | MN20160304_L01 | L22 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 9.16 | 771.67 | 1010 | 1138 | 0.8871 | 0.6156 | MN20160304_L01 | D07 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 9.16 | 771.67 | 1194 | 1138 | 1.0487 | 1.1771 | MN20160304_L01 | L22 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 11.56 | 771.67 | 1099 | 1280 | 0.8582 | 0.6223 | MN20160304_L01 | D07 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 11.56 | 771.67 | 1315 | 1280 | 1.0268 | 1.0738 | MN20160304_L01 | L22 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 13.78 | 771.67 | 1220 | 1459 | 0.8358 | 0.6455 | MN20160304_L01 | D07 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 13.78 | 771.67 | 1465 | 1459 | 1.0036 | 1.0078 | MN20160304_L01 | L22 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 16.00 | 771.67 | 1294 | 1585 | 0.8162 | 0.6448 | MN20160304_L01 | D07 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 16.00 | 771.67 | 1532 | 1585 | 0.9663 | 0.9350 | MN20160304_L01 | L22 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 18.22 | 771.67 | 1331 | 1741 | 0.7643 | 0.5909 | MN20160304_L01 | D07 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 18.22 | 771.67 | 1573 | 1741 | 0.9033 | 0.8341 | MN20160304_L01 | L22 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 20.44 | 771.67 | 1336 | 1910 | 0.6992 | 0.5213 | MN20160304_L01 | D07 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 20.44 | 771.67 | 1564 | 1910 | 0.8185 | 0.7161 | MN20160304_L01 | L22 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 22.66 | 771.67 | 1332 | 2141 | 0.6220 | 0.4488 | MN20160304_L01 | D07 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 22.66 | 771.67 | 1574 | 2141 | 0.7350 | 0.6227 | MN20160304_L01 | L22 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 24.89 | 771.67 | 1319 | 2397 | 0.5501 | 0.3878 | MN20160304_L01 | D07 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 24.89 | 771.67 | 1569 | 2397 | 0.6544 | 0.5432 | MN20160304_L01 | L22 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 27.11 | 771.67 | 1349 | 2675 | 0.5043 | 0.3654 | MN20160304_L01 | D07 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 27.11 | 771.67 | 1555 | 2675 | 0.5813 | 0.4780 | MN20160304_L01 | L22 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 29.33 | 771.67 | 1328 | 2939 | 0.4518 | 0.3249 | MN20160304_L01 | D07 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 29.33 | 771.67 | 1524 | 2939 | 0.5185 | 0.4229 | MN20160304_L01 | L22 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 31.55 | 771.67 | 1323 | 3196 | 0.4139 | 0.3007 | MN20160304_L01 | D07 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 31.55 | 771.67 | 1574 | 3196 | 0.4924 | 0.4157 | MN20160304_L01 | L22 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 33.78 | 771.67 | 1295 | 3499 | 0.3700 | 0.2679 | MN20160304_L01 | D07 |
MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 33.78 | 771.67 | 1529 | 3499 | 0.4369 | 0.3682 | MN20160304_L01 | L22 |